| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/23/2008 | EP1914310A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/23/2008 | EP1914301A1 Anti-CD80 antibodies |
| 04/23/2008 | EP1914244A2 Method of modulating the activity of functional immune molecules |
| 04/23/2008 | EP1914243A2 Anti-CD40 monoclonal antibody |
| 04/23/2008 | EP1914242A1 Novel anti-CD38 antibodies for the treatment of cancer |
| 04/23/2008 | EP1914239A1 Attentuated gram negative bacteria |
| 04/23/2008 | EP1913952A1 Molecular determinants of myeloma bone disease and uses thereof |
| 04/23/2008 | EP1913137A1 Serine beta-lactamase-like / d-aia carboxypeptidase-like protein |
| 04/23/2008 | EP1913028A2 Use of antibody to m-csf |
| 04/23/2008 | EP1913027A2 M-csf specific monoclonal antibody and uses thereof |
| 04/23/2008 | EP1913026A1 Modified antibody fragments |
| 04/23/2008 | EP1913023A1 Novel anticoagulant polypeptides and complex |
| 04/23/2008 | EP1912675A2 B-cell reduction using cd37-specific and cd20-specific binding molecules |
| 04/23/2008 | EP1912674A2 Bispecific single chain fv antibody molecules and methods of use thereof |
| 04/23/2008 | EP1912671A2 Beta-glucuronide-linker drug conjugates |
| 04/23/2008 | EP1912667A2 Concentrated protein lyophilates, methods, and uses |
| 04/23/2008 | EP1912665A2 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 04/23/2008 | EP1774033A4 Multiplexing assays for analyte detection |
| 04/23/2008 | EP1699822B1 Il-7 fusion proteins with antibody portions, their preparation and their use |
| 04/23/2008 | EP1639137A4 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 04/23/2008 | EP1606387A4 Vectors used to create hybrid constant regions |
| 04/23/2008 | EP1462457B1 Cytotoxic protein and utilization thereof |
| 04/23/2008 | EP1422243B1 Humanized antibody against fibroblast growth factor-8 and fragment of the antibody |
| 04/23/2008 | EP1372712B1 Equine herpesvirus vaccine |
| 04/23/2008 | EP1354889B1 Transcription activation complex and utilization thereof |
| 04/23/2008 | EP1284993B1 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella paraperussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 04/23/2008 | EP1220921B1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/23/2008 | EP1021728B8 Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins |
| 04/23/2008 | EP0988317B1 Aib1, a steroid receptor co-activator |
| 04/23/2008 | EP0948630B1 Cloning and characterization of napsin, an aspartic protease |
| 04/23/2008 | EP0906417B1 Cross-linked protein crystal formulations and their use as catalysts in organic solvents |
| 04/23/2008 | CN101166976A ELISA assays using prion-specific peptide reagents |
| 04/23/2008 | CN101166825A Novel regulation protein |
| 04/23/2008 | CN101166764A 骨病症的治疗 The treatment of bone disorders |
| 04/23/2008 | CN101166763A Stabilized anti-hepatitis B (HBV) antibody formulations |
| 04/23/2008 | CN101166755A Single chain antibody with cleavable linker |
| 04/23/2008 | CN101166542A KIM-1 antibodies for treatment of TH2-mediated conditions |
| 04/23/2008 | CN101165178A RBP4 antibody and its preparation method and use |
| 04/23/2008 | CN101165069A Preparation for self-protein used as carrier protein for hapten-antibody |
| 04/23/2008 | CN101165068A Monoclonal antibody for resisting HER2/ErbB2 antigen, preparation method and medicament composition thereof |
| 04/23/2008 | CN101164616A Uses of anti-insulin-like growth factor 1 receptor antibodies |
| 04/23/2008 | CN100383244C Method for manufacturing recombinant polyclonal proteins |
| 04/23/2008 | CN100383238C Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom |
| 04/23/2008 | CN100383163C Antibody for inhibiting blood coagulation and method of use thereof |
| 04/23/2008 | CN100383162C Combination detection reagent for detecting schistosomiasis and detecting method thereof |
| 04/23/2008 | CN100383158C Method and compositions for peptide synthesis |
| 04/23/2008 | CN100382844C Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and use of anti-lymphotoxin ligand antibodies |
| 04/22/2008 | US7361748 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/22/2008 | US7361741 Antibody, or fragment thereof, capable of binding specifically to human pancreatic lipase |
| 04/22/2008 | US7361740 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| 04/22/2008 | US7361517 Diagnosis and/or monitoring of patients with systemic lupus erythematosus by isolating reticulocytes from a blood sample, determining the level of a C4d complement pathway component on the reticulocytes, and comparing it to a control level; an elevated lovel indicates an acute inflammatory episode |
| 04/22/2008 | US7361511 Comparing gene expression levels in normal and tumor cells, diagnosis, treating with an antisense oligonucleotide, and monitoring results |
| 04/22/2008 | US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase |
| 04/22/2008 | US7361475 Compositions and methods relating to colon specific genes and proteins |
| 04/22/2008 | US7361464 Method, systems and kits for immuno-detection of epitopes expressed on molecules |
| 04/22/2008 | US7361463 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage |
| 04/22/2008 | US7361359 Neospora caninum isolate |
| 04/22/2008 | US7361350 Use of an IL-1 antagonist for treating arthritis |
| 04/22/2008 | US7361348 Immunogenic glycopeptides, screening, preparation and uses |
| 04/22/2008 | US7361345 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug |
| 04/22/2008 | US7361344 Co-administration of a thrombolytic and an-anti-CD18 antibody in stroke |
| 04/22/2008 | US7361343 Customization of cancer therapy by adminstering modifying antibodies from antigens expressed from cancerous tissue which are cytotoxic to cancer cells while non-toxic to non-cancerous cells; monoclonal antibody antigen binding fragment having identifying characteristics to deposit PTA-4890 at the ATCC |
| 04/22/2008 | US7361342 Cancerous disease modifying antibodies |
| 04/22/2008 | US7361341 Methods of treating cancer using antibodies that immunospecifically bind to trail receptors |
| 04/22/2008 | US7361340 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy |
| 04/22/2008 | US7361339 Methods for reducing morality associated with acute myocardial infarction |
| 04/22/2008 | US7361338 Methods to inhibit growth of prostate cancer cells |
| 04/22/2008 | US7361337 Antibodies against the PRO1754 polypeptides |
| 04/22/2008 | US7361334 Method of treatment of diabetes through induction of immunological tolerance |
| 04/22/2008 | US7361333 Creating tolerance to transplanted cells, tissue, or organs without the need for continuous immunosuppression. A tolerizing dose of a cell or tissue within a membrane structure is implanted into a patient. Once the patient |
| 04/22/2008 | CA2390685C Methods and compositions for inhibiting neoplastic cell growth |
| 04/22/2008 | CA2297694C Antibodies and diagnostic methods for the diagnosis of pestviruses |
| 04/22/2008 | CA2265936C Process for producing a plasma protein-containing medicament |
| 04/17/2008 | WO2008046033A2 Enhancement of hybridoma fusion efficiencies through cell synchronization |
| 04/17/2008 | WO2008045252A2 Engineered integrin binding peptides |
| 04/17/2008 | WO2008044957A1 Proteom differential analysis method |
| 04/17/2008 | WO2008044754A1 Prophylactic or therapeutic agent for cancer |
| 04/17/2008 | WO2008044599A1 Polypeptide having activity of targeting intestine having inflammation, and use thereof |
| 04/17/2008 | WO2008044351A1 Novel transporter protein in mammal, and use thereof |
| 04/17/2008 | WO2008044076A2 Therapy targeting cathepsin s |
| 04/17/2008 | WO2008043777A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 04/17/2008 | WO2008043146A1 Antibodies against non functional p2x7 receptor |
| 04/17/2008 | WO2008043145A1 Hybridomas producing antibodies against non functional p2x7 receptor |
| 04/17/2008 | WO2008015480A3 Composition and method for modulating an immune response |
| 04/17/2008 | WO2008003103A3 Novel multivalent immunoglobulins |
| 04/17/2008 | WO2007076062A3 Protein formulations with reduced viscosity and uses thereof |
| 04/17/2008 | WO2006133144A8 Erythropoietin receptor peptide formulations and uses |
| 04/17/2008 | US20080090994 Novel Antigen Constructs Useful In the Detection and Differentiation of Antibodies to HIV |
| 04/17/2008 | US20080090993 Recombinant cytotoxic lymphocyte-8 for use as regulator of hematopoietic cells; treating infections, allergies and cell proliferative disorders |
| 04/17/2008 | US20080090778 Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof |
| 04/17/2008 | US20080090768 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 04/17/2008 | US20080090762 Epithelum-derived T-cell factor |
| 04/17/2008 | US20080090758 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| 04/17/2008 | US20080090750 N-terminal sequences of human growth hormone, human placental lactogen, human growth hormone variant hGH-V, and prolactin; used in inhibiting angiogenesis, antiproliferative, and in the diagnosis of diseases of human pregnancy involving abnormal placenta, preeclampsia and intrauterine growth retardation |
| 04/17/2008 | US20080090290 Nucleic Acids Encoding Anti-IL-12 Antibodies, and Methods of Production |
| 04/17/2008 | US20080090271 Polypeptides having glucoamylase activity and polynucleotides encoding same |
| 04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |
| 04/17/2008 | US20080090257 Compositions and methods for inhibiting or inducing adipogenesis |
| 04/17/2008 | US20080090250 Using coded antibodies as evaluative tools in diagnosis of viral or bacterial infections |
| 04/17/2008 | US20080090249 Ube2g2 Binding Domain in The Ubiquitin Ligase Gp78 And Methods Of Use Thereof |